Navigation Links
Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run
Date:9/16/2010

SAN FRANCISCO, Sept. 16 /PRNewswire/ -- In response to recent press coverage concerning investment to support the development of a biobusiness park in Minnesota, Burrill & Company would like to clarify that investment discussions are still ongoing.

"We have been in active discussions for several months with one potential investor who has an interest in the project," said G. Steven Burrill, CEO, Burrill & Company. "However, contrary to the impressions conveyed in the press coverage, no decisions have yet been made and there can be no guarantees about the actual outcome at this point.

"We do have a strong interest in the State of Minnesota and independent of our continuing efforts at Elk Run, we have been actively investing in the State, creating jobs and establishing an innovative biotech venture capital community," Burrill added. "We have already established an office in Minnesota and are actively investing in promising start-up companies. Bringing more than $100 million into the State in the last year is evidence of our significant ongoing commitment to Minnesota, independent of the potential fund commitment."

Burrill & Company investments in Minnesota:

- Invested $8M in Nora Therapeutics, developer of women's reproductive health drugs and devices. Burrill's investment also brought an additional $17M into the company, as part of a syndicate with Prospect Venture Partners and Vivo Ventures.

- In 2009, Burrill & Company invested $5M in Segetis, a start-up company developing chemicals made from biomass. The total investment into the company was over $17M, with additional syndicate member Khosla Ventures. Segetis is located in Golden Valley, MN.

- This year, one of Burrill & Company's portfolio companies, GEVO, acquired a corn-based ethanol plant owned and operated by Agri-Energy in Luverne, MN. The transaction, worth over $20M, will bring the latest isobutanol technology into the State as well as gene
'/>"/>

SOURCE Burrill & Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Shawn Cross Joins Burrill Merchant Banking
2. Burrill & Company Invests in Taiwan Liposome Company
3. Joao Paulo Baptista Joins Burrill & Company
4. CEO of Burrill & Company to Speak at BioConference Live Slated for November 17th and 18th
5. Burrill & Company and WR Hambrecht + Co to Collaborate on OpenIPO(R) Transactions
6. Shawn Cross Appointed CEO of Burrill Merchant Banking Group
7. CardioWest™ Artificial Heart Approved For Highest Reimbursement in CMS History : Plus Up To $53,000 New Technology Add-on Payments
8. 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis
9. Bruker Introduces HyperQuant™, a Unique Bench-Top NMR Reader to Quantify Hyperpolarization
10. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
11. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... -- Pfenex Inc. (NYSE MKT: PFNX) a clinical-stage biotechnology company ... value and difficult to manufacture proteins, today announced the ... of its common stock at a price to the ... offered, 2,610,000 are being offered by Pfenex and the ... Pfenex will not receive any proceeds from the shares ...
(Date:4/24/2015)... 24, 2015 Seoul Semiconductor announced ... various applications in the lighting market. In ... of this technology in emerging markets such as ... wide range of applications such as streetlight and ... lighting. , First launched in 2005 the Acrich ...
(Date:4/23/2015)... , April 23, 2015 /CNW/ - A new and ... award from North America,s ... Comparison won Silver in the "Sustainability, service" category ... The Brandcheck "Competitor Comparison" is a service that ... American and Global peers. This benchmarking process shows ...
(Date:4/23/2015)... April 23, 2015 WuXi PharmaTech (Cayman) Inc. ... and technology platform company serving the pharmaceutical, biotechnology and ... and the United States ... for the first quarter of 2015 after the New ... (which will be Thursday morning, May 14, 2015 Shanghai ...
Breaking Biology Technology:Pfenex Inc. Announces Pricing Of Follow-on Offering 2Acrich Technology from Seoul Semiconductor Adopted in Installations Worldwide 2WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release 2WuXi PharmaTech Schedules First-Quarter 2015 Earnings Release 3
... Renovis,Inc. (Nasdaq: RNVS ), a biopharmaceutical company ... medical needs in the areas of,neurological and inflammatory diseases, ... 30, 2007. Revenue for the third quarter and ... and $8.5 million, respectively, compared to $2.2,million and $8.3 ...
... Pathwork Diagnostics, a,genomics-based diagnostics company focused on oncology, ... has initiated an,investigational study of the Pathwork(TM) Tissue ... to help determine a tumor,s origin so that,tissue-specific ... of the first,institutions in the country to evaluate ...
... Airborne Biological Threats Receives Government ... ... ICx Technologies, a developer of,advanced technology solutions for homeland and ... ambient aerosol,sensors for detection of airborne biological threats. The AirSentinel,sensors, ...
Cached Biology Technology:Renovis Reports Third Quarter 2007 Financial Results 2Renovis Reports Third Quarter 2007 Financial Results 3Renovis Reports Third Quarter 2007 Financial Results 4Renovis Reports Third Quarter 2007 Financial Results 5Renovis Reports Third Quarter 2007 Financial Results 6Renovis Reports Third Quarter 2007 Financial Results 7Renovis Reports Third Quarter 2007 Financial Results 8Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin 2Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin 3Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics' Tissue of Origin Test Designed to Aid in Determination of a Tumor's Origin 4ICx Awarded Department of Defense Contract for AirSentinel Monitors 2
(Date:3/24/2015)... NexID Biometrics LLC, whose spoof-mitigation technology boosts protection ... beginning of shipments of version 2.0 of its industry ... in Potsdam, N.Y. , is making ... here today at the Walter E. Washington Convention Center. ... boosts the accuracy rate range to 96.5 to 99.5 ...
(Date:3/23/2015)... SoundView Technology Group issues a new research update following the ... wallet. SoundView was one of the selected user groups to provide ... in multiple scenarios and outlets. Soundview shares ... both debit and credit card payments.  Soundview ... meets their plans in 2015, it would push our IV ...
(Date:3/23/2015)... 2015  In the 2014 fiscal year, irs.gov recorded ... This figure accounts for a fraction of the estimated ... Report, exceeds $11 billion globally. The polygraph has traditionally ... has occurred. Investor Mark Saint Juste along ... Paolella partnered to administer the test in a ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... can serve as important sources of social and emotional support ... according to research published by the American Psychological Association. ... close to key people in their lives as to their ... the expense of relationships with other people, or that people ...
... technical, medical, and scholarly (STMS) business of global publisher ... increase in the number and proportion of its journal ... included in the Thomson ISI 2010 Journal Citation Reports ... from the 2009 JCR and includes 58 titles which ...
... vitamin D insufficiency and deficiency among patients with psoriatic ... observed in patients in southern or northern locations. The ... , a journal of the American College of Rheumatology ... vitamin D level. Psoriasis is a common ...
Cached Biology News:The truth about cats and dogs: Pets are good for mental health of 'everyday people' 2Wiley-Blackwell announces continued growth in impact factor journals 2Wiley-Blackwell announces continued growth in impact factor journals 3Wiley-Blackwell announces continued growth in impact factor journals 4Wiley-Blackwell announces continued growth in impact factor journals 5Vitamin D insufficiency prevalent among psoriatic arthritis suffers 2
...
... Cell Dissociation Buffers are membrane-filtered ... salts chelating agents and cell-conditioning agents ... balanced salt solution or Ca2+- ... dissociation of mammalian cells from support ...
... are membrane-filtered isotonic and enzyme-free aqueous ... cell-conditioning agents in either Ca2+- and ... Ca2+- and Mg2+-free phosphate-buffered saline ... from support substrates and each other ...
... Antibody Modification Services ,,GenScript offers ... labeling and antibody fragmentation. Labeling antibodies ... for visualization and quantitation of the ... is preferable to use only the ...
Biology Products: